Application no. and date | 14751357.6 (espacenet) (Federated) (European Patent Register), 20140214 | Patent/reg. no. and date | DK/EP 2956176, 20180627 | Publication date | 20151223 | Priority no. and date | US 201361764969 P, 20130214, US 201361880779 P, 20130920 | EP pub. no. and date |
EP 2956176 20151223 | Effective date | | Applicant/owner | Ionis Pharmaceuticals, Inc., 2855 Gazelle Court
Carlsbad, CA 92010, US | Applicant ref. no. | P65116DK01 | Inventor | WITZTUM, Joseph, L., 6912 Ofria Court
San Diego, CA 92120, US, ALEXANDER, Veronica, J., 2855 Gazelle Court
Carlsbad, CA 92010, US, VINEY, Nicholas, J., 2855 Gazelle Court
Carlsbad, CA 92010, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | Opponent | | IPC Class | A61K 31/7088 (2006.01) , C12N 15/113 (2010.01) | Title | MODULATION AF APOLIPOPROTEIN C-III (APOCIII)-EKSPRESSION I LIPOPROTEIN LIPASE-DEFICIENTE (LPLD)-POPULATIONER | Int. application no. | US2014016546 | Int. publication no. | WO2014127268 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|